secwatch.observer — SEC 8-K summary
======================================

Issuer:     ANAVEX LIFE SCIENCES CORP. (AVXL)
CIK:        0001314052
Form:       8-K
Filed at:   2022-03-04T23:59:59+00:00
Accession:  0001731122-22-000366
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 4.01, 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Anavex Life Sciences changes auditor from BDO to Grant Thornton LLP; no disagreements reported
--------------------------------------------------------------------------------

- Dismissed BDO as independent auditor on March 1, 2022; no adverse opinions or disagreements in prior two fiscal years.
- Engaged Grant Thornton as new independent auditor for FY ending Sep 30, 2022 after competitive process by Audit Committee.
- Entered Amendment No.2 to employment agreement with Principal Financial Officer Sandra Boenisch, effective March 1, 2022, increasing annual base salary to $240,000 CAD.
- Press release issued March 4, 2022 announcing the auditor change.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1314052/000173112222000366/0001731122-22-000366-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1314052/000173112222000366/e3562_8-k.htm
  HTML page:      https://secwatch.observer/filing/0001731122-22-000366

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer